Biotech’s boardroom gains for women fail to translate to CEO roles
Women held 29% of biotech board seats in fiscal 2025 but just 8.8% of CEO roles, highlighting uneven progress across industry leadership spots.
Women held 29% of biotech board seats in fiscal 2025 but just 8.8% of CEO roles, highlighting uneven progress across industry leadership spots.
comments(0)
5-min edit window · permanent after that